RxDoctor Payments Data

Katie Krause, MD

Neurological Surgery · Seattle, WANPI 1881950772

Payments from drug & device makers

What this record shows

This record is dominated by travel and lodging: $13,049 of the $17,173 with a category attached, or 76.0%. 15 manufacturers reported payments, led by Globus Medical at 26.1% of the total. Reporting peaked in 2024 at $5,796 and has fallen 64.6% since, to $2,051 in 2025.

$17,173in general payments, 2019–2025

Across 121 payments — averaging $141.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Globus Medical$4K
  • Medtronic$4K
  • Alphatec Spine, Inc$3K
  • Surgalign Spine Technologies, Inc.$1K
  • Medical Device Business Services, Inc.$1K
  • Augmedics Inc.$1K
  • plus $2K from 9 others

What the payments were for

  • Travel & lodging$13,04976%
  • Food & beverage$4,12424%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,173 in reported general payments places this provider in the 80th percentile of 175 neurological surgery providers in Washington.

See all neurological surgery providers in Washington

Medicare billing

Part B allowed, 2024
$132,555
Medicare patients
193
Services billed
405

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Cyclobenzaprine Hcl27$528
Gabapentin44$451
Methocarbamol19$211
Methylprednisolone31$194
Tizanidine Hcl17$170
Pregabalin14$144
Oxycodone Hcl17$91
Meloxicam29$53

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Seattle

See the full list for Washington

Where these figures come from

Is this you, or does something look wrong? →